ArticleThyroid : official journal of the American Thyroid Association2014

A phase I study of cabozantinib (XL184) in patients with differentiated thyroid cancer.

Maria E Cabanillas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.